BioSpace News Archive

Megaphone with stethoscope isolated on orange background. 3d illustration

Biotech Leaders, Investors Ask FDA to Maintain Access to Mifepristone

An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater restrictions on the abortion pill.

July 3, 2025

·

2 min read

·

Tristan Manalac

Minimal icon featuring open blue padlock with white upward arrow passing through it, symbolizing security, access, or unlocking new opportunities, digital access, data protection, 3d rendering

Accelerated approval

Regeneron Scores Multiple Myeloma Nod for Bispecific, Unlocking $600M Opportunity

While it trails Johnson & Johnson’s Tecvayli, Regeneron still hopes Lynozyfic can differentiate in terms of dosing convenience and efficacy.

July 3, 2025

·

2 min read

·

Tristan Manalac

Close-Up Of Syringe With Bottles Against Blue Background

RSV

Kennedy Follows RSV Recommendations of ACIP Members He Fired

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are at risk of severe disease.

July 3, 2025

·

3 min read

·

Tristan Manalac

Pictured: Office building science collage

Career Advice

The Top 12 Companies Hiring in Biopharma Now

Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.

July 3, 2025

·

1 min read

·

Angela Gabriel

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

4DMT Thins Early-Stage Workforce, Focuses on Late-Stage Activities

Follow along as BioSpace tracks job cuts and restructuring initiatives throughout 2025.

July 3, 2025

·

152 min read

·

BioSpace Editorial Staff

vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake

Immunology and inflammation

Late-Stage Stumble for Cosentyx Sets Novartis Back in Autoimmune Condition

Novartis is falling farther behind AbbVie, which expanded its JAK inhibitor Rinvoq into giant cell arteritis in April.

July 3, 2025

·

2 min read

·

Tristan Manalac

Job Trends

Bioinformatics Roles in Increasing Demand, Critical to Industry, Personalized Medicine

Bioinformatics is on the rise, forecasted to grow by about $16 billion from 2024 to 2029 given its value to managing mass datasets critical to modern drug discovery and development. Two talent acquisition experts share how the field has evolved in the past few years and which skills are most in demand.

July 3, 2025

·

5 min read

·

Angela Gabriel

Social media illustration, business concept, web design

Mergers & acquisitions

Sage’s Search for Lifeline Ran Into Defiant Biogen CEO

After the FDA rejection of Zurzuvae in one type of depression and the triple failure of neuro asset dalzanemdor, Sage was searching for a path forward at the end of December 2024. Biogen CEO Chris Viehbacher spied a possible deal, but the smaller company wasn’t interested.

July 3, 2025

·

3 min read

·

Annalee Armstrong

Press Releases

Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30

July 3, 2025

·

3 min read

Press Releases

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - July 2, 2025

July 3, 2025

·

2 min read